Abouth this book
Following the two meetings on Lactoferrin Structure and Function that were held in Honolulu, Hawaii, in 1993 and 1995, the Third International Conference on Lactoferrin Structure and Function was held in Le Touquet, France, and has successfully reinforced and diversified the previously created bridges between biochemists, clinicians, and companies. In fact, scientists, physicians, and people of industry from different domains have brought a wealth of recent information concerning biochemistry and technical advances in the identification of lactoferrin-derived compounds as well as cell biology, molecular biol ogy, pathology, and medical applications of lactoferrin and lactoferrin-derived com pounds.
We were so delighted with the rapid growth of knowledge concerning many biologi cal and immunological functions of lactoferrins and the relationships between their struc ture and function, we wanted to share our pleasure with the readers interested in this field. The present book. which represents a review of some of the most exciting contributions, is intended to reflect the status of our knowledge and transmit our hopes for the future devel opment of in vivo applications of natural and recombinant lactoferrins. We would like to express our gratitude to the sponsors who contributed to the or ganization of the meeting in such a pleasant place and allowed the participation of several young researchers. We would also like to thank all the participants who have answered with enthusiasm our invitation and to every one of the Laboratoire de Chimie Biologique for the constant and efficient help.
https://www.springer.com/gp/book/9780306459269
Bibliography:
- Awadasseid A. et al.; Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Int J Biol Sci. 2020 Apr 6;16(11):1846-1860. doi: 10.7150/ijbs.45018. eCollection 2020.
- Binte Aziz Asma; Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? Biosafety and Health, 2020
- Blaess M. et al.; COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. Int J Mol Sci. 2020 Jul 13;21(14):4953. doi: 10.3390/ijms21144953.
- Campione Elena et al.; Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation; Int. J. Mol. Sci. 2020, 21(14), 4903
- Chang Raymond, Tzi Bun Ng, Wei-ZenSun; Lactoferrin as potential preventative and adjunct treatment for COVID-19; International Journal of Antimicrobial Agents Volume 56, Issue 3, September 2020, 106118
- Church Dawson et al., App-Based Delivery of Clinical Emotional Freedom Techniques: Cross-Sectional Study of App User Self-Ratings; JMIR Mhealth Uhealth, 2020
- Deshmukh V, et al.; COVID-19: a conundrum to decipher. Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
- Drago-Serrano et al.; Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections; Int J Mol Sci, 2017
- Fernández-Lázaro Diego et al.; Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy? Int J Environ Res Public Health
- Jawhara et al.; Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Int J Mol Sci, 2020
- Mirabelli Carmen et al.; Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19; BioRxiv. Preprint. NaN NaN [revised 2020 Sep 28].
Original articol
- Root‐Bernstein Robert Age and Location in Severity of COVID‐19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences?
https://www.youtube.com/watch?v=GODBYRbPL00&feature=youtu.be
Original article
Original article
- Universidad Peruana Cayetano Heredia; Lactoferrin for Prevention of COVID-19 in Health Care Workers
- Università Tor Vergata - Una risposta contro il Covid-19: la glicoproteina lattoferrina, una componente dell’immunità innata
- Zhai Xiaofeng et al; Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.; J Virol. 2020 Jul 16;94(15):e00831-20. doi: 10.1128/J. Vi.00831-20. Print 2020 Jul 16.
- Zhang Wan-Ying et al.: Molecular mechanism prediction analysis of compound Kushen injection in the treatment of COVID-19 based on network pharmacology and molecular docking. Traditional Medicine Research 2020, 5 (5): 413-424. doi: 10.12032/TMR20200518180
- Zhang Wan-Ying et al.; Treating COVID-19 by traditional Chinese medicine: a charming strategy?Traditional Medicine Research 2020, Vol. 5 Issue (4): 178-181
